These results on pre-diagnosed DM were supported by a nested case–control study that found an increased risk of PCa in patients with increased marker levels of hyperglycaemia (glycated haemoglobin, HbA1c) and peripheral insulin resistance (plasma insulin and proinsulin) [155]. This evidence concerns the gene INS and Hyperglycemia.